Cartesian Therapeutics
Signal active
Organization
Contact Information
Overview
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
About
Industries
Biotechnology, Oncology
Founded
2016
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cartesian Therapeutics headquartered in United States, North America, operates in the Biotechnology, Oncology sector. The company focuses on Biotechnology and has secured $3.2B in funding across 24 round(s). With a team of 11-50 employees, Cartesian Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Cartesian Therapeutics, raised $130.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
5
Lead Investors
0
Total Funding Amount
$132.0M
Details
0
Cartesian Therapeutics has raised a total of $132.0M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Cartesian Therapeutics is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| HBM Healthcare Investments | - | FUNDING ROUND - HBM Healthcare Investments | 130.0M |
| Schooner Capital | - | FUNDING ROUND - Schooner Capital | 130.0M |
| Cartesian Therapeutics | - | FUNDING ROUND - Cartesian Therapeutics | 130.0M |
| Invus | - | FUNDING ROUND - Invus | 130.0M |
Recent Activity
There is no recent news or activity for this profile.